FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16049911000001104: Doxazosin 2mg tablets (Bristol Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56622201000001119 Doxazosin 2mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56622301000001111 Doxazosin 2mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doxazosin 2mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Bristol Laboratories Ltd) Is a Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Bristol Laboratories Ltd) Has active ingredient Doxazosin mesilate false Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Bristol Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Bristol Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Doxazosin mesilate true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Bristol Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Bristol Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Bristol Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Bristol Laboratories Ltd) Has basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Doxazosin 2mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has AMP True Doxazosin 2mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start